Superworth

BioNexus Gene Lab EPS BGLC

Diluted earnings per share by quarter and over the last twelve months, from 2018.

Last 12 months, to Jun 30, 2026
−$1.25
Latest quarter, Q2 FY26
−$0.12
Fiscal year 2025
−$1.59

BioNexus Gene Lab's earnings per share was −$1.25 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.12.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.59n/a
FY2022$0.00n/a
FY2021$0.00n/a
FY2020$0.00n/a
FY2019$0.00n/a
FY2018n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.12n/a−$1.25
Q1 FY26−$0.23n/a−$1.47
Q4 FY25−$0.51n/a−$1.59
Q3 FY25−$0.40n/an/a
Q2 FY25−$0.34−404%n/a
Q1 FY25−$0.35n/an/a
Q3 FY24−$0.75n/an/a
Q2 FY24$0.11n/an/a
Q1 FY24−$0.01n/an/a
Q2 FY23$0.00n/a$0.00
Q1 FY23$0.00n/a$0.00
Q4 FY22$0.00n/a$0.00

Against its peers

Companies in Healthcare nearest BioNexus Gene Lab's size, closest first, today.

CompanyEPS, 12 monthsGrowth
BGLCBioNexus Gene Lab−$1.25
OXBROXBRIDGE RE HOLDINGS$0.02
EDUCEducational Development$0.19
GTIMGood Times Restaurants$0.21+75% a year
MDRRMedalist Diversified$3.84
BCGBinah Capital$0.16
VIPVulcan Infrastructure & Power$0.07
MXCMexco Energy$0.75−5% a year
CKXCKX Lands$1.42+647% a year
MSGMMotorsport Games$0.43+187% a year
ATCHAtlasClear$0.01
Peer median$0.20

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on BioNexus Gene Lab

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.